AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2016
Mar 8, 2016
31529_dirs_2016-03-08_ab038968-5b29-4088-952d-7d8ecca675c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-08-25
Reporting Person: Thomas John C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-25 | Common Stock | G | 15736 | $0.00 | Disposed | 76839 | Direct |
| 2015-08-31 | Common Stock | G | 2775 | $0.00 | Disposed | 74064 | Direct |
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24